Soy isoflavones and prostate cancer: A review of molecular mechanisms

Journal of Steroid Biochemistry and Molecular Biology

Volumn 140, Issue , 2014, Pages 116-132

  Mahmoud, Abeer M ^a   Yang, Wancai ^a,b   Bosland, Maarten C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Chemoprevention; Genistein; Isoflavone; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; BETA CATENIN; ESTROGEN RECEPTOR; HISTONE; ISOFLAVONE DERIVATIVE; MICRORNA; PROSTAGLANDIN; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CHEMOSENSITIVITY; DNA METHYLATION; DNA REPAIR; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME INHIBITION; EPIGENETICS; FIBROBLAST; HISTONE MODIFICATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; METASTASIS; METASTASIS INHIBITION; PROSTAGLANDIN METABOLISM; PROSTATE CANCER; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION;

ACTIVATED PROTEIN KINASE; ADENOMATOUS POLYPOSIS COLI; APC; APE1/REF; APK; APURINIC APYRIMIDINIC ENDONUCLEASE REDOX EFFECTOR FACTOR; B-CELL TRANSLOCATION GENE; BTG; CANCER STEM CELLS; CHEMOPREVENTION; COLONY-STIMULATING FACTOR; CSC; CSF; DISHEVELED; DSH; ECGF1; ENDOTHELIAL CELL GROWTH FACTOR; EPHB; EPHRIN B; FAK; FOCAL ADHESION KINASE; GADD; GENISTEIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE S-TRANSFERASE P; GLYCOGEN SYNTHASE KINASE 3Β; GLYCOGEN SYNTHASE KINASE-3Β; GM-CSF; GPX; GRANULOCYTE MONOCYTE-COLONY STIMULATING FACTOR; GROWTH ARREST AND DNA DAMAGE; GSK-3Β; GSK3Β; GSR; GSTP; HAT; HISTONE ACETYLTRANSFERASES; ISOFLAVONE; LEF; LHRH; LUTEINIZING HORMONE RELEASING HORMONE; LYMPHOID ENHANCER FACTOR; N-BENZYLOXYCARBONYL-VAL-ASP-FLUOROMETHYL-KETONE; PROSTATE CANCER; RAS ASSOCIATION DOMAIN FAMILY; RASSF; TAMS; TRIM; TRIPARTITE MOTIF-CONTAINING PROTEIN; TUMOR ASSOCIATED MACROPHAGES; UPA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; Z-VAD-FMK;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL DIFFERENTIATION; DNA REPAIR; EPIGENESIS, GENETIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISOFLAVONES; MALE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PROSTAGLANDINS; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; RADIATION-SENSITIZING AGENTS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SOYBEANS; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84892162689     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.12.010     Document Type: Review

References (205)

1. R. Siegel, C. Desantis, K. Virgo, K. Stein, and A. Mariotto et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J. Clin. 62 2012 220 241
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, and E. Ward et al. Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
3. T. Kimura East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians Chin. J. Cancer 31 September (9) 2012 421 429
4. H. Adlercreutz, H. Markkanen, and S. Watanabe Plasma concentrations of phyto-oestrogens in Japanese men Lancet 342 1993 1209 1210 (Pubitemid 23331713)
5. M.S. Morton, P.S. Chan, C. Cheng, N. Blacklock, and A. Matos-Ferreira et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom Prostate 32 1997 122 128 (Pubitemid 27280356)
6. Y.W. Hwang, S.Y. Kim, S.H. Jee, Y.N. Kim, and C.M. Nam Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies Nutr. Cancer 61 2009 598 606
7. G. Maskarinec, Y. Morimoto, S. Hebshi, S. Sharma, and A.A. Franke et al. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men Eur. J. Clin. Nutr. 60 2006 1423 1429 (Pubitemid 44857629)
8. K.F. Adams, C. Chen, K.M. Newton, J.D. Potter, and J.W. Lampe Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial Cancer Epidemiol. Biomarkers Prev. 13 2004 644 648 (Pubitemid 38737902)
9. D.J. Jenkins, C.W. Kendall, M.A. D'Costa, C.J. Jackson, and E. Vidgen et al. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men J. Urol. 169 2003 507 511 (Pubitemid 36132973)
10. J.M. Hamilton-Reeves, S.A. Rebello, W. Thomas, M.S. Kurzer, and J.W. Slaton Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer Nutr. Cancer 60 2008 7 13 (Pubitemid 351192916)
11. D. Urban, W. Irwin, M. Kirk, M.A. Markiewicz, and R. Myers et al. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen J. Urol. 165 2001 294 300
12. R.W. deVere White, A. Tsodikov, E.C. Stapp, S.E. Soares, and H. Fujii et al. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer Nutr. Cancer 62 2010 1036 1043
13. N.B. Kumar, A. Cantor, K. Allen, D. Riccardi, and K. Besterman-Dahan et al. The specific role of isoflavones in reducing prostate cancer risk Prostate 59 2004 141 147 (Pubitemid 38481225)
14. M.C. Bosland, I. Kato, A. Zeleniuch-Jacquotte, J. Schmoll, and E. Enk Rueter et al. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial J. Am. Med. Assoc. 310 2013 170 178
15. J.K. Napora, R.G. Short, D.C. Muller, O.D. Carlson, and J.O. Odetunde et al. High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer J. Androl. 32 2011 40 48
16. R.W. deVere White, R.M. Hackman, S.E. Soares, L.A. Beckett, and Y. Li et al. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer Urology 63 2004 259 263 (Pubitemid 38234414)
17. W. Kwan, G. Duncan, C. Van Patten, M. Liu, and J. Lim A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer Nutr. Cancer 62 2010 198 207
18. J.M. Pendleton, W.W. Tan, S. Anai, M. Chang, and W. Hou et al. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy BMC Cancer 8 2008 132
19. E.M. Grainger, S.J. Schwartz, S. Wang, N.Z. Unlu, and T.W. Boileau et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen Nutr. Cancer 60 2008 145 154 (Pubitemid 351451270)
20. B. Lazarevic, G. Boezelijn, L.M. Diep, K. Kvernrod, and O. Ogren et al. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind phase 2 clinical trial Nutr. Cancer 63 2011 889 898
21. F.S. Dalais, A. Meliala, N. Wattanapenpaiboon, M. Frydenberg, and D.A. Suter et al. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer Urology 64 2004 510 515 (Pubitemid 39200748)
22. M. Hussain, M. Banerjee, F.H. Sarkar, Z. Djuric, and M.N. Pollak et al. Soy isoflavones in the treatment of prostate cancer Nutr. Cancer 47 2003 111 117 (Pubitemid 38590881)
23. S. Swami, A.V. Krishnan, J. Moreno, R.S. Bhattacharyya, and C. Gardner et al. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients Int. J. Cancer 124 2009 2050 2059
24. J.M. Hamilton-Reeves, S.A. Rebello, W. Thomas, J.W. Slaton, and M.S. Kurzer Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer J. Nutr. 137 2007 1769 1775 (Pubitemid 47037705)
25. G.E. Joannou, G.E. Kelly, A.Y. Reeder, M. Waring, and C. Nelson A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids J. Steroid Biochem. Mol. Biol. 54 1995 167 184
26. C.H. Takimoto, K. Glover, X. Huang, S.A. Hayes, and L. Gallot et al. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer Cancer Epidemiol. Biomarkers Prev. 12 2003 1213 1221 (Pubitemid 37499447)
27. K.D. Setchell, M.S. Faughnan, T. Avades, L. Zimmer-Nechemias, and N.M. Brown et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women Am. J. Clin. Nutr. 77 2003 411 419 (Pubitemid 36133385)
28. C.D. Gardner, B. Oelrich, J.P. Liu, D. Feldman, and A.A. Franke et al. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation Prostate 69 2009 719 726
29. L.T. Bloedon, A.R. Jeffcoat, W. Lopaczynski, M.J. Schell, and T.M. Black et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women Am. J. Clin. Nutr. 76 2002 1126 1137 (Pubitemid 35244688)
30. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, and S.H. Safe et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263 (Pubitemid 28513713)
31. K. Morito, T. Hirose, J. Kinjo, T. Hirakawa, and M. Okawa et al. Interaction of phytoestrogens with estrogen receptors alpha and beta Biol. Pharm. Bull. 24 2001 351 356 (Pubitemid 32377601)
32. J. An, C. Tzagarakis-Foster, T.C. Scharschmidt, N. Lomri, and D.C. Leitman Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens J. Biol. Chem. 276 2001 17808 17814
33. L. Zhao, Z. Mao, and R.D. Brinton A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo Endocrinology 150 2009 770 783
34. E.P. Moiseeva, G.M. Almeida, G.D. Jones, and M.M. Manson Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells Mol. Cancer Ther. 6 2007 3071 3079 (Pubitemid 350206785)
35. L.H. Touny, and P.P. Banerjee Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein Prostate 66 2006 1542 1555 (Pubitemid 44465819)
36. Y. Li, M. Bhuiyan, and F.H. Sarkar Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein Int. J. Oncol. 15 1999 525 533
37. M.B. Ruiz-Larrea, A.R. Mohan, G. Paganga, N.J. Miller, and G.P. Bolwell et al. Antioxidant activity of phytoestrogenic isoflavones Free Radic. Res. 26 1997 63 70 (Pubitemid 27060130)
38. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, and S. Watanabe et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases J. Biol. Chem. 262 1987 5592 5595
39. Y. Li, and F.H. Sarkar Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway Clin. Cancer Res. 8 2002 2369 2377 (Pubitemid 34753612)
40. J.N. Davis, O. Kucuk, and F.H. Sarkar Genistein inhibits NF-kappa B activation in prostate cancer cells Nutr. Cancer 35 1999 167 174 (Pubitemid 30115128)
41. A.M. Mahmoud, T. Zhu, A. Parray, H.R. Siddique, and W. Yang et al. Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor PLoS ONE 8 2013 e78479
42. Y.J. Seo, B.S. Kim, S.Y. Chun, Y.K. Park, and K.S. Kang et al. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1 J. Korean Med. Sci. 26 2011 1489 1494
43. R. Agarwal Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents Biochem. Pharmacol. 60 2000 1051 1059
44. B.F. Wang, J.S. Wang, J.F. Lu, T.H. Kao, and B.H. Chen Antiproliferation effect and mechanism of prostate cancer cell lines as affected by isoflavones from soybean cake J. Agric. Food Chem. 57 2009 2221 2232
45. T.E. Hedlund, W.U. Johannes, and G.J. Miller Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro Prostate 54 2003 68 78 (Pubitemid 36043838)
46. J.C. Shen, R.D. Klein, Q. Wei, Y. Guan, and J.H. Contois et al. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells Mol. Carcinog. 29 2000 92 102
47. R. Zhao, N. Xiang, F.E. Domann, and W. Zhong Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells Nutr. Cancer 61 2009 397 407
48. J.J. Raffoul, Y. Wang, O. Kucuk, J.D. Forman, and F.H. Sarkar et al. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest BMC Cancer 6 2006 107
49. B.M. Burgering A brief introduction to FOXOlogy Oncogene 27 2008 2258 2262 (Pubitemid 351501787)
50. M.J. Christensen, T.E. Quiner, H.L. Nakken, E.D. Lephart, and D.L. Eggett et al. Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer Prostate 73 2013 986 995
51. S.K. Roy, R.K. Srivastava, and S. Shankar Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer J. Mol. Signal. 5 2010 10
52. Y. Takahashi, J.A. Lavigne, S.D. Hursting, G.V. Chandramouli, and S.N. Perkins et al. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray Mol. Carcinog. 45 2006 943 956 (Pubitemid 44907384)
53. N. Rabiau, M. Kossai, M. Braud, N. Chalabi, and S. Satih et al. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines Cancer Epidemiol. 34 2010 200 206
54. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, and S.M. Shalet et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353 (Pubitemid 38529873)
55. E.E. Ozkan Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review Mol. Cell. Endocrinol. 344 2011 1 24
56. C. Gennigens, C. Menetrier-Caux, and J.P. Droz Insulin-Like Growth Factor (IGF) family and prostate cancer Crit. Rev. Oncol. Hematol. 58 2006 124 145
57. H. Werner, and D. Le Roith New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia Cell. Mol. Life Sci. 57 2000 932 942 (Pubitemid 30461834)
58. J. Lee, J. Ju, S. Park, S.J. Hong, and S. Yoon Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of beta-catenin signaling in hormone refractory PC-3 prostate cancer cells Nutr. Cancer 64 2012 153 162
59. B. Valentinis, and R. Baserga IGF-I receptor signalling in transformation and differentiation Mol. Pathol. 54 2001 133 137 (Pubitemid 32539602)
60. B. Valentinis, G. Romano, F. Peruzzi, A. Morrione, and M. Prisco et al. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways J. Biol. Chem. 274 1999 12423 12430
61. S. Wang, V.L. DeGroff, and S.K. Clinton Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase J. Nutr. 133 2003 2367 2376 (Pubitemid 36841567)
62. K.R. Diener, E.F. Need, G. Buchanan, and J.D. Hayball TGF-beta signalling and immunity in prostate tumourigenesis Expert Opin. Ther. Targets 14 2010 179 192
63. E. Jones, H. Pu, and N. Kyprianou Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression Expert Opin. Ther. Targets 13 2009 227 234
64. X. Huang, S. Chen, L. Xu, Y. Liu, and D.K. Deb et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells Cancer Res. 65 2005 3470 3478 (Pubitemid 40524634)
65. L. Xu, and R.C. Bergan Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway Mol. Pharmacol. 70 2006 869 877 (Pubitemid 44268444)
66. Y. Li, and F.H. Sarkar Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein Cancer Lett. 186 2002 157 164 (Pubitemid 35246201)
67. C. Yost, M. Torres, J.R. Miller, E. Huang, and D. Kimelman et al. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3 Genes Dev. 10 1996 1443 1454 (Pubitemid 26260702)
68. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev. Cell 17 2009 9 26
69. C. Patriarca, D. Petrella, B. Campo, P. Colombo, and P. Giunta et al. Elevated E-cadherin and alpha/beta-catenin expression after androgen deprivation therapy in prostate adenocarcinoma Pathol. Res. Pract. 199 2003 659 665 (Pubitemid 37493372)
70. N. Morita, H. Uemura, K. Tsumatani, M. Cho, and Y. Hirao et al. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion Br. J. Cancer 79 1999 1879 1883 (Pubitemid 29132319)
71. M. Jaggi, S.L. Johansson, J.J. Baker, L.M. Smith, and A. Galich et al. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer Urol. Oncol. 23 2005 402 406 (Pubitemid 41654506)
72. M.A. Liss, M. Schlicht, A. Kahler, R. Fitzgerald, and T. Thomassi et al. Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer Cancer Genomics Proteomics 7 2010 245 252
73. J.R. Graff, B.W. Konicek, A.M. McNulty, Z. Wang, and K. Houck et al. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression J. Biol. Chem. 275 2000 24500 24505 (Pubitemid 30626543)
74. H. Murillo, H. Huang, L.J. Schmidt, D.I. Smith, and D.J. Tindall Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state Endocrinology 142 2001 4795 4805 (Pubitemid 33022355)
75. J.I. Kreisberg, S.N. Malik, T.J. Prihoda, R.G. Bedolla, and D.A. Troyer et al. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer Cancer Res. 64 2004 5232 5236 (Pubitemid 39006542)
76. A.R. Uzgare, and J.T. Isaacs Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells Cancer Res. 64 2004 6190 6199 (Pubitemid 39129421)
77. Y. Li, Z. Wang, D. Kong, R. Li, and S.H. Sarkar et al. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells J. Biol. Chem. 283 2008 27707 27716
78. C.G. Tepper, R.L. Vinall, C.B. Wee, L. Xue, and X.B. Shi et al. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms Prostate 67 2007 521 535 (Pubitemid 46536945)
79. H.Y. Oh, J. Leem, S.J. Yoon, S. Yoon, and S.J. Hong Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor Biochem. Biophys. Res. Commun. 393 2010 319 324
80. H. Skogseth, T. Follestad, E. Larsson, and J. Halgunset Transcription levels of invasion-related genes in prostate cancer cells are modified by inhibitors of tyrosine kinase Acta Pathol. Microbiol. Immunol. Scand. 114 2006 364 371 (Pubitemid 43829427)
81. R.L. Vinall, K. Hwa, P. Ghosh, C.X. Pan, and P.N. Lara Jr. et al. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis Clin. Cancer Res. 13 2007 6204 6216 (Pubitemid 350075082)
82. F. Cao, T.Y. Jin, and Y.F. Zhou Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene Biomed. Environ. Sci. 19 2006 35 41
83. R. Kumar, V. Verma, A. Jain, R.K. Jain, and J.P. Maikhuri et al. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer J. Nutr. Biochem. 22 2011 723 731
84. J. Kumi-Diaka, N.A. Sanderson, and A. Hall The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP Biol. Cell 92 2000 595 604 (Pubitemid 32366627)
85. A. Kazi, K.G. Daniel, D.M. Smith, N.B. Kumar, and Q.P. Dou Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein Biochem. Pharmacol. 66 2003 965 976 (Pubitemid 37083593)
86. A. Hsu, T.M. Bray, W.G. Helferich, D.R. Doerge, and E. Ho Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells Exp. Biol. Med. (Maywood) 235 2010 90 97
87. Y. Li, and F.H. Sarkar Gene expression profiles of genistein-treated PC3 prostate cancer cells J. Nutr. 132 2002 3623 3631 (Pubitemid 35435038)
88. E.A. Clubbs, and J.A. Bomser Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein Nutr. Cancer 61 2009 390 396
89. R. Mentor-Marcel, C.A. Lamartiniere, I.E. Eltoum, N.M. Greenberg, and A. Elgavish Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP) Cancer Res. 61 2001 6777 6782 (Pubitemid 32896500)
90. K. Singletary, and J. Milner Diet, autophagy, and cancer: a review Cancer Epidemiol. Biomarkers Prev. 17 2008 1596 1610
91. S. Alers, A.S. Loffler, S. Wesselborg, and B. Stork Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks Mol. Cell. Biol. 32 2012 2 11
92. Y. Nakamura, S. Yogosawa, Y. Izutani, H. Watanabe, and E. Otsuji et al. A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy Mol. Cancer 8 2009 100
93. G. Gossner, M. Choi, L. Tan, S. Fogoros, and K.A. Griffith et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells Gynecol. Oncol. 105 2007 23 30 (Pubitemid 46441453)
94. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur Free radicals, metals and antioxidants in oxidative stress-induced cancer Chem. Biol. Interact. 160 2006 1 40 (Pubitemid 43227479)
95. P. Pugalendhi, S. Manoharan, K. Panjamurthy, S. Balakrishnan, and M.R. Nirmal Antigenotoxic effect of genistein against 7,12-dimethylbenz[a]anthracene induced genotoxicity in bone marrow cells of female Wistar rats Pharmacol. Rep. 61 2009 296 303
96. H.Y. Leung, L.H. Yung, C.H. Poon, G. Shi, and A.L. Lu et al. Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A Br. J. Nutr. 101 2009 257 262
97. N. Khan, F. Afaq, and H. Mukhtar Cancer chemoprevention through dietary antioxidants: progress and promise Antioxid. Redox Signal. 10 2008 475 510
98. P. Foti, D. Erba, P. Riso, A. Spadafranca, and F. Criscuoli et al. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes Arch. Biochem. Biophys. 433 2005 421 427 (Pubitemid 39592796)
99. K. Suzuki, H. Koike, H. Matsui, Y. Ono, and M. Hasumi et al. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3 Int. J. Cancer 99 2002 846 852 (Pubitemid 34575703)
100. M. Raschke, I.R. Rowland, P.J. Magee, and B.L. Pool-Zobel Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress Carcinogenesis 27 2006 2322 2330 (Pubitemid 44644823)
101. C.E. Park, H. Yun, E.B. Lee, B.I. Min, and H. Bae et al. The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells J. Med. Food 13 2010 815 820
102. T. Oki, Y. Sowa, T. Hirose, N. Takagaki, and M. Horinaka et al. Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line FEBS Lett. 577 2004 55 59 (Pubitemid 39452360)
103. T. Hussain, S. Gupta, and H. Mukhtar Cyclooxygenase-2 and prostate carcinogenesis Cancer Lett. 191 2003 125 135 (Pubitemid 36255597)
104. A.F. Badawi The role of prostaglandin synthesis in prostate cancer BJU Int. 85 2000 451 462 (Pubitemid 30142622)
105. A.T. Koki, and J.L. Masferrer Celecoxib: a specific COX-2 inhibitor with anticancer properties Cancer Control 9 2002 28 35 (Pubitemid 34457338)
106. J.C. Otto, and W.L. Smith Prostaglandin endoperoxide synthases-1 and -2 J. Lipid Mediat. Cell Signal. 12 1995 139 156
107. E. Fosslien Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis Ann. Clin. Lab. Sci. 31 2001 325 348 (Pubitemid 32988657)
108. G. Aparicio Gallego, S. Diaz Prado, P. Jimenez Fonseca, R. Garcia Campelo, and J. Cassinello Espinosa et al. Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer Clin. Transl. Oncol. 9 2007 694 702
109. S. Swami, A.V. Krishnan, J. Moreno, R.B. Bhattacharyya, and D.M. Peehl et al. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer J. Nutr. 137 2007 205S 210S (Pubitemid 46052882)
110. M.R. Alison, S.M. Lim, and L.J. Nicholson Cancer stem cells: problems for therapy? J. Pathol. 223 2011 147 161
111. W.W. Barclay, L.S. Axanova, W. Chen, L. Romero, and S.L. Maund et al. Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation Stem Cells 26 2008 600 610
112. H.F. English, R.J. Santen, and J.T. Isaacs Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement Prostate 11 1987 229 242 (Pubitemid 18004762)
113. D.G. Tang, L. Patrawala, T. Calhoun, B. Bhatia, and G. Choy et al. Prostate cancer stem/progenitor cells: identification, characterization, and implications Mol. Carcinog. 46 2007 1 14 (Pubitemid 46095228)
114. K.G. Leong, B.E. Wang, L. Johnson, and W.Q. Gao Generation of a prostate from a single adult stem cell Nature 456 2008 804 808
115. X. Wang, M. Kruithof-de Julio, K.D. Economides, D. Walker, and H. Yu et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer Nature 461 2009 495 500
116. L. Patrawala, T. Calhoun, R. Schneider-Broussard, H. Li, and B. Bhatia et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
117. J.A. McCubrey, W.H. Chappell, S.L. Abrams, R.A. Franklin, and J.M. Long et al. Targeting the cancer initiating cell: the Achilles' heel of cancer Adv. Enzyme Regul. 51 2011 152 162
118. J.A. McCubrey, S.L. Abrams, K. Stadelman, W.H. Chappell, and M. Lahair et al. Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells Adv. Enzyme Regul. 50 2010 285 307
119. H. Ouchi, H. Ishiguro, N. Ikeda, M. Hori, and Y. Kubota et al. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity Int. J. Urol. 12 2005 73 80 (Pubitemid 40333005)
120. R.K. Montgomery, D.L. Carlone, C.A. Richmond, L. Farilla, and M.E. Kranendonk et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells Proc. Natl. Acad. Sci. U.S.A. 108 2011 179 184
121. B. Molinie, and P. Georgel Genetic and epigenetic regulations of prostate cancer by genistein Drug News Perspect. 22 2009 247 254
122. M. Adjakly, R. Bosviel, N. Rabiau, J.P. Boiteux, and Y.J. Bignon et al. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines Epigenomics 3 2011 795 803
123. A. Vardi, R. Bosviel, N. Rabiau, M. Adjakly, and S. Satih et al. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells In Vivo 24 2010 393 400
124. S. Majid, A.A. Dar, V. Shahryari, H. Hirata, and A. Ahmad et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer Cancer 116 2010 66 76
125. N. Kikuno, H. Shiina, S. Urakami, K. Kawamoto, and H. Hirata et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells Int. J. Cancer 123 2008 552 560 (Pubitemid 351898412)
126. M.Z. Fang, D. Chen, Y. Sun, Z. Jin, and J.K. Christman et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy Clin. Cancer Res. 11 2005 7033 7041 (Pubitemid 41428763)
127. M. Bulger Hyperacetylated chromatin domains: lessons from heterochromatin J. Biol. Chem. 280 2005 21689 21692 (Pubitemid 40827814)
128. J.W. Catto, A. Alcaraz, A.S. Bjartell, R. De Vere White, and C.P. Evans et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review Eur. Urol. 59 2011 671 681
129. Y. Li, D. Kong, A. Ahmad, B. Bao, and G. Dyson et al. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion Epigenetics 7 2012 940 949
130. N. Rabiau, H.K. Trraf, M. Adjakly, R. Bosviel, and L. Guy et al. miRNAs differentially expressed in prostate cancer cell lines after soy treatment In Vivo 25 2011 917 921
131. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410 (Pubitemid 37328844)
132. R. Ambra, G. Rimbach, S. de Pascual Teresa, D. Fuchs, and U. Wenzel et al. Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells Nutr. Metab. Cardiovasc. Dis. 16 2006 35 43
133. X. Yu, J. Zhu, M. Mi, W. Chen, and Q. Pan et al. Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation Med. Oncol. 29 2012 349 357
134. Y. Guo, S. Wang, D.R. Hoot, and S.K. Clinton Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones J. Nutr. Biochem. 18 2007 408 417 (Pubitemid 46727041)
135. A. Pines, L. Perrone, N. Bivi, M. Romanello, and G. Damante et al. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP Nucleic Acids Res. 33 2005 4379 4394 (Pubitemid 41222553)
136. J.J. Raffoul, S. Banerjee, V. Singh-Gupta, Z.E. Knoll, and A. Fite et al. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo Cancer Res. 67 2007 2141 2149 (Pubitemid 46424233)
137. V. Singh-Gupta, H. Zhang, S. Banerjee, D. Kong, and J.J. Raffoul et al. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells Int. J. Cancer 124 2009 1675 1684
138. J.R. Zhou, E.T. Gugger, T. Tanaka, Y. Guo, and G.L. Blackburn et al. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice J. Nutr. 129 1999 1628 1635 (Pubitemid 29406613)
139. R. Handayani, L. Rice, Y. Cui, T.A. Medrano, and V.G. Samedi et al. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells J. Nutr. 136 2006 75 82 (Pubitemid 43156488)
140. S. Lehrer, E.J. Diamond, B. Mamkine, N.N. Stone, and R.G. Stock Serum interleukin-8 is elevated in men with prostate cancer and bone metastases Technol. Cancer Res. Treat. 3 2004 411 (Pubitemid 39391995)
141. H. Uehara, P. Troncoso, D. Johnston, C.D. Bucana, and C. Dinney et al. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage Prostate 64 2005 40 49 (Pubitemid 40734737)
142. K. Inoue, J.W. Slaton, B.Y. Eve, S.J. Kim, and P. Perrotte et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer Clin. Cancer Res. 6 2000 2104 2119 (Pubitemid 30305111)
143. C.A. Klein Cancer. The metastasis cascade Science 321 2008 1785 1787
144. L.L. Zhang, L. Li, D.P. Wu, J.H. Fan, and X. Li et al. A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells Acta Pharmacol. Sin. 29 2008 1060 1068
145. J. Xu, R. Wang, Z.H. Xie, V. Odero-Marah, and S. Pathak et al. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis Prostate 66 2006 1664 1673 (Pubitemid 44646357)
146. J.K. Kumi-Diaka, M. Hassanhi, K. Merchant, and V. Horman Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells J. Med. Food 9 2006 491 497 (Pubitemid 46095357)
147. Y. Li, O. Kucuk, M. Hussain, J. Abrams, and M.L. Cher et al. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer Cancer Res. 66 2006 4816 4825
148. M. Lakshman, L. Xu, V. Ananthanarayanan, J. Cooper, and C.H. Takimoto et al. Dietary genistein inhibits metastasis of human prostate cancer in mice Cancer Res. 68 2008 2024 2032 (Pubitemid 351416590)
149. Y. Liu, E. Kyle, R. Lieberman, J. Crowell, and G. Kellof et al. Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation Clin. Exp. Metastasis 18 2000 203 212 (Pubitemid 32269989)
150. L. Xu, S. Chen, and R.C. Bergan MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer Oncogene 25 2006 2987 2998 (Pubitemid 43780463)
151. R. Mentor-Marcel, C.A. Lamartiniere, I.A. Eltoum, N.M. Greenberg, and A. Elgavish Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP) J. Nutr. 135 2005 989 995 (Pubitemid 40638296)
152. L.H. El Touny, and P.P. Banerjee Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis Cancer Res. 69 2009 3695 3703
153. G.N. Thalmann, R.A. Sikes, R.E. Devoll, J.A. Kiefer, and R. Markwalder et al. Osteopontin: possible role in prostate cancer progression Clin. Cancer Res. 5 1999 2271 2277 (Pubitemid 29399287)
154. J. Bouchal, F.R. Santer, P.P. Hoschele, E. Tomastikova, and H. Neuwirt et al. Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer Prostate 71 2011 431 437
155. K. Miekus, and Z. Madeja Genistein inhibits the contact-stimulated migration of prostate cancer cells Cell. Mol. Biol. Lett. 12 2007 348 361
156. J.R. Zhou, L. Yu, Y. Zhong, R.L. Nassr, and A.A. Franke et al. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components Prostate 53 2002 143 153
157. I.B. Joseph, and J.T. Isaacs Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents J. Natl. Cancer Inst. 90 1998 1648 1653 (Pubitemid 28523439)
158. M. Wang, Y. Hu, I. Shima, and M.E. Stearns IL-10/IL-10 receptor signaling regulates TIMP-1 expression in primary human prostate tumor lines Cancer Biol. Ther. 1 2002 556 563
159. J. Seibel, A.F. Molzberger, T. Hertrampf, U. Laudenbach-Leschowski, and P. Diel Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis Eur. J. Nutr. 48 2009 213 220
160. G. Ji, Q. Yang, J. Hao, L. Guo, and X. Chen et al. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms Int. Immunopharmacol. 11 2011 762 768
161. M.T. Velasquez, and S.J. Bhathena Dietary phytoestrogens: a possible role in renal disease protection Am. J. Kidney Dis. 37 2001 1056 1068 (Pubitemid 32436581)
162. F. Afaq, and S.K. Katiyar Polyphenols: skin photoprotection and inhibition of photocarcinogenesis Mini Rev. Med. Chem. 11 2011 1200 1215
163. G.G. Hillman, Y. Wang, O. Kucuk, M. Che, and D.R. Doerge et al. Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model Mol. Cancer Ther. 3 2004 1271 1279 (Pubitemid 39440172)
164. S.J. Hong, S.I. Kim, S.M. Kwon, J.R. Lee, and B.C. Chung Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia Yonsei Med. J. 43 2002 236 241 (Pubitemid 34498427)
165. M. Bolla, L. Collette, L. Blank, P. Warde, and J.B. Dubois et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 2002 103 106
166. R.M. Hermann, H.A. Wolff, H. Jarry, P. Thelen, and C. Gruendker et al. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol Radiat. Oncol. 3 2008 19
167. G.G. Hillman, J.D. Forman, O. Kucuk, M. Yudelev, and R.L. Maughan et al. Genistein potentiates the radiation effect on prostate carcinoma cells Clin. Cancer Res. 7 2001 382 390 (Pubitemid 32183043)
168. J.J. Raffoul, S. Banerjee, M. Che, Z.E. Knoll, and D.R. Doerge et al. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model Int. J. Cancer 120 2007 2491 2498 (Pubitemid 46642139)
169. S.Y. Ping, T.C. Hour, S.R. Lin, and D.S. Yu Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth Urol. Oncol. 28 2010 170 179
170. R.A. Burich, W.S. Holland, R.L. Vinall, C. Tepper, and R.W. White et al. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines BJU Int. 102 2008 1458 1466
171. C. Huggins Effect of orchiectomy and irradiation on cancer of the prostate Ann. Surg. 115 1942 1192 1200
172. M.E. Grossmann, H. Huang, and D.J. Tindall Androgen receptor signaling in androgen-refractory prostate cancer J. Natl. Cancer Inst. 93 2001 1687 1697 (Pubitemid 33130257)
173. J.D. Debes, and D.J. Tindall Mechanisms of androgen-refractory prostate cancer N. Engl. J. Med. 351 2004 1488 1490 (Pubitemid 39315314)
174. I.U. Agoulnik, and N.L. Weigel Androgen receptor action in hormone-dependent and recurrent prostate cancer J. Cell. Biochem. 99 2006 362 372 (Pubitemid 44435554)
175. P. Koivisto, J. Kononen, C. Palmberg, T. Tammela, and E. Hyytinen et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Res. 57 1997 314 319 (Pubitemid 27036612)
176. C.W. Gregory, B. He, R.T. Johnson, O.H. Ford, and J.L. Mohler et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy Cancer Res. 61 2001 4315 4319 (Pubitemid 32685750)
177. P. Li, X. Yu, K. Ge, J. Melamed, and R.G. Roeder et al. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer Am. J. Pathol. 161 2002 1467 1474
178. M.J. Linja, K.P. Porkka, Z. Kang, K.J. Savinainen, and O.A. Janne et al. Expression of androgen receptor coregulators in prostate cancer Clin. Cancer Res. 10 2004 1032 1040 (Pubitemid 38202234)
179. T. Chen, L.H. Wang, and W.L. Farrar Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells Cancer Res. 60 2000 2132 2135 (Pubitemid 30225173)
180. N. Craft, Y. Shostak, M. Carey, and C.L. Sawyers A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase Nat. Med. 5 1999 280 285 (Pubitemid 29124362)
181. P. Kupelian, J. Katcher, H. Levin, C. Zippe, and E. Klein Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer Urology 48 1996 249 260 (Pubitemid 26279618)
182. M.C. Luke, and D.S. Coffey Human androgen receptor binding to the androgen response element of prostate specific antigen J. Androl. 15 1994 41 51 (Pubitemid 24061785)
183. W.A. Fritz, J. Wang, I.E. Eltoum, and C.A. Lamartiniere Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate Mol. Cell. Endocrinol. 186 2002 89 99 (Pubitemid 34189782)
184. J. Wang, I.E. Eltoum, and C.A. Lamartiniere Genistein chemoprevention of prostate cancer in TRAMP mice J. Carcinog. 6 2007 3
185. J.N. Davis, O. Kucuk, and F.H. Sarkar Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells Mol. Carcinog. 34 2002 91 101 (Pubitemid 34606511)
186. S. Basak, D. Pookot, E.J. Noonan, and R. Dahiya Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function Mol. Cancer Ther. 7 2008 3195 3202
187. Y. Takahashi, J.A. Lavigne, S.D. Hursting, G.V. Chandramouli, and S.N. Perkins et al. Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets Mol. Carcinog. 41 2004 108 119 (Pubitemid 39336760)
188. F. Payton-Stewart, N.W. Schoene, Y.S. Kim, M.E. Burow, and T.E. Cleveland et al. Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP Mol. Carcinog. 48 2009 862 871
189. J. Bektic, A.P. Berger, K. Pfeil, G. Dobler, and G. Bartsch et al. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta Eur. Urol. 45 2004 245 251 discussion 251 (Pubitemid 38147834)
190. B. Lazarevic, S.J. Karlsen, and F. Saatcioglu Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells Oncol. Rep. 19 2008 1231 1235
191. S. Gao, G.Z. Liu, and Z. Wang Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells Prostate 59 2004 214 225 (Pubitemid 38481232)
192. M. Maggiolini, A. Vivacqua, A. Carpino, D. Bonofiglio, and G. Fasanella et al. The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells Mol. Pharmacol. 62 2002 1027 1035 (Pubitemid 35229971)
193. M.C. Bosland The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention Rev. Urol. 7 Suppl. 3 2005 S4 S10
194. H. Bonkhoff, T. Fixemer, I. Hunsicker, and K. Remberger Estrogen receptor expression in prostate cancer and premalignant prostatic lesions Am. J. Pathol. 155 1999 641 647 (Pubitemid 29370414)
195. T. Fixemer, K. Remberger, and H. Bonkhoff Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma Prostate 54 2003 79 87 (Pubitemid 36120323)
196. I. Leav, K.M. Lau, J.Y. Adams, J.E. McNeal, and M.E. Taplin et al. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma Am. J. Pathol. 159 2001 79 92 (Pubitemid 33704195)
197. W.A. Ricke, S.J. McPherson, J.J. Bianco, G.R. Cunha, and Y. Wang et al. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J. 22 2008 1512 1520 (Pubitemid 351656791)
198. D. Price, B. Stein, P. Sieber, R. Tutrone, and J. Bailen et al. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial J. Urol. 176 2006 965 970 discussion 970-961
199. Z. Weihua, S. Makela, L.C. Andersson, S. Salmi, and S. Saji et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc. Natl. Acad. Sci. U.S.A. 98 2001 6330 6335 (Pubitemid 32492315)
200. O. Imamov, A. Morani, G.J. Shim, Y. Omoto, and C. Thulin-Andersson et al. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate Proc. Natl. Acad. Sci. U.S.A. 101 2004 9375 9380 (Pubitemid 38821066)
201. S.J. McPherson, S. Hussain, P. Balanathan, S.L. Hedwards, and B. Niranjan et al. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated Proc. Natl. Acad. Sci. U.S.A. 107 2010 3123 3128
202. X. Zhu, I. Leav, Y.K. Leung, M. Wu, and Q. Liu et al. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis Am. J. Pathol. 164 2004 2003 2012 (Pubitemid 38669349)
203. W.Y. Chang, and G.S. Prins Estrogen receptor-beta: implications for the prostate gland Prostate 40 1999 115 124 (Pubitemid 29304702)
204. T. Sonoda, H. Suzuki, M. Mori, T. Tsukamoto, and A. Yokomizo et al. Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men Eur. J. Cancer Prev. 19 2010 131 137
205. M. Iwasaki, G.S. Hamada, I.N. Nishimoto, M.M. Netto, and J. Motola Jr. et al. Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians Cancer Sci. 100 2009 927 933